%PDF-1.4
%
280 0 obj
<>
endobj
270 0 obj
<>
endobj
269 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows)
Arbortext Advanced Print Publisher 10.0.1465/W Unicode
2024-03-28T17:29:13-07:00
2017-03-21T15:21:37+05:30
2024-03-28T17:29:13-07:00
application/pdf
Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis
uuid:d3bf2514-56ba-48b8-a8a8-2c5cd71d41d3
uuid:0c92adbd-1dd2-11b2-0a00-9000d85ed0ff
endstream
endobj
281 0 obj
<>
endobj
177 0 obj
<>
endobj
267 0 obj
<>
endobj
5 0 obj
<>
endobj
266 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/Properties<>/Shading<>/XObject<>>>/Rotate 0/Thumb 197 0 R/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 2 0 R/Type/Page>>
endobj
44 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 45 0 R/Type/Page>>
endobj
60 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 61 0 R/Type/Page>>
endobj
74 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 90/Thumb 75 0 R/Type/Page>>
endobj
78 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/Thumb 79 0 R/Type/Page>>
endobj
94 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Thumb 95 0 R/Type/Page>>
endobj
103 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 104 0 R/Type/Page>>
endobj
115 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 116 0 R/Type/Page>>
endobj
142 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 143 0 R/Type/Page>>
endobj
585 0 obj
<>stream
HWr}WHXN=I-KآT,R9$'..OwJ⭔DsN>yMڼ|M6_nؿ ܬn)-#28\pr{s;|2},hҙ^M'aMnƙn0Wr8V6OfD۴G%z@T